Cerdulatinib (PRT-062070, PRT2070) 是一种具有口服活性的多靶点酪氨酸激酶抑制剂,对JAK1/JAK2/JAK3/TYK2和Syk的IC50分别为12 nM/6 nM/8 nM/0.5 nM和32 nM,也能够抑制测试的其他19种激酶,IC50均低于200 nM。 Information Cerdulatinib (PRT062070, PRT2070) is a potent and selective inhibitor of Tyk2 with IC50 of 0.5 nM. Cerdulatinib is also a dual inhibitor of JAK and SYK with IC50 of 12 nM, 6 nM, 8 nM and 32 nM for JAK1, JAK2, JAK3 and SYK, respectively.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Cerdulatinib
CAS number:1198300-79-6 molecular formula:C20H27N7O3S
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | HY-15999 | s3566 | AS-56368 | Q27075860 | Cerdulatinib | PRT2070 | PRT-2070 | Z1509507773 | RVT-502 | 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide | SB16931 | 2,4,6-trinitro-toluene | AKOS026750510 | Ce | ||
| CAS number | 1198300-79-6 | molecular formula | C20H27N7O3S |
| molecular weight | 445.54 g/mol | Exact mass | - |
| PSA | 142.000 Ų | logp | 1.900 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





